Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial "ARTE"


Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Patients undergoing a TAVI procedure with the Edwards SAPIEN XT valve (transfemoral or transapical)

Exclusion Criteria

- Need for chronic anticoagulation treatment
- Major bleeding within the 3 months prior to the TAVI procedure
- Prior intracranial bleeding
- Drug-eluting stent implantation within the year prior to the TAVI procedure
- Allergy to clopidogrel and/or aspirin